BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 391529)

  • 1. Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Dec; 18(6):417-38. PubMed ID: 391529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiaprofenic acid. A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states.
    Sorkin EM; Brogden RN
    Drugs; 1985 Mar; 29(3):208-35. PubMed ID: 3886353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.
    Brogden RN; Heel RC; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Jul; 20(1):24-48. PubMed ID: 6772422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenoprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.
    Brogden RN; Pinder RM; Speight TM; Avery GS
    Drugs; 1977 Apr; 13(4):241-65. PubMed ID: 324748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European experience with flurbiprofen. A new analgesic/anti-inflammatory agent.
    Buchanan WW; Kassam YB
    Am J Med; 1986 Mar; 80(3A):145-52. PubMed ID: 3963022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Oct; 18(4):241-77. PubMed ID: 387372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-month prospective study to monitor the treatment of rheumatic diseases with sustained-release flurbiprofen.
    Rovenský J; Miceková D
    Drugs Exp Clin Res; 2000; 26(1):19-24. PubMed ID: 10761533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenbufen: a review of its pharmacological properties and therapeutic use in rheumatic diseases and acute pain.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1981 Jan; 21(1):1-22. PubMed ID: 7009135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with phenylbutazone.
    Lomen PL; Turner LF; Lamborn KR; Brinn EL; Sattler LP
    Am J Med; 1986 Mar; 80(3A):120-6. PubMed ID: 3963017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of flurbiprofen and indomethacin administered orally and rectally in chronic rheumatic conditions.
    Pawlotsky Y
    Panminerva Med; 1984; 26(1):49-53. PubMed ID: 6610162
    [No Abstract]   [Full Text] [Related]  

  • 11. Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.
    Friedel HA; Todd PA
    Drugs; 1988 May; 35(5):504-24. PubMed ID: 3293969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pirprofen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Todd PA; Beresford R
    Drugs; 1986 Dec; 32(6):509-37. PubMed ID: 3539573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of flurbiprofen in the treatment of ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis. A summary of liver and kidney assay data.
    Lomen PL; Turner LF; Lamborn KR
    Am J Med; 1986 Mar; 80(3A):23-30. PubMed ID: 3963024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some biological properties of flurbiprofen, an anti-inflammatory, analgesic and antipyretic agent.
    Adams SS; McCullough KF; Nicholson JS
    Arzneimittelforschung; 1975 Nov; 25(11):1786-91. PubMed ID: 1081878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with indomethacin.
    Lomen PL; Turner LF; Lamborn KR; Brinn EL
    Am J Med; 1986 Mar; 80(3A):127-32. PubMed ID: 3963018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alclofenac: a review of its pharmacological properties and therapeutic efficacy in rheumatoid arthritis and allied rheumatic disorders.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1977 Oct; 14(4):241-59. PubMed ID: 21068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flurbiprofen in the symptomatic management of rheumatoid arthritis: a valuable alternative.
    Richy F; Rabenda V; Mawet A; Reginster JY
    Int J Clin Pract; 2007 Aug; 61(8):1396-406. PubMed ID: 17596188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaprozin. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Todd PA; Brogden RN
    Drugs; 1986 Oct; 32(4):291-312. PubMed ID: 3536423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long-term assessment of flurbiprofen.
    Sheldrake FE; Webber JM; Marsh BD
    Curr Med Res Opin; 1977; 5(1):106-16. PubMed ID: 71968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naproxen: a review of its pharmacological properties and therapeutic efficacy and use.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1975; 9(5):326-63. PubMed ID: 1097233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.